The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis

IF 4.6 2区 医学 Q1 RHEUMATOLOGY Seminars in arthritis and rheumatism Pub Date : 2024-10-11 DOI:10.1016/j.semarthrit.2024.152570
Edward Lovering , Chanakya Kodishala , Roslin Jose George , Rakesh Kumar , Cynthia S Crowson , Ryan J Lennon , John M Davis III , Elena Myasoedova
{"title":"The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis","authors":"Edward Lovering ,&nbsp;Chanakya Kodishala ,&nbsp;Roslin Jose George ,&nbsp;Rakesh Kumar ,&nbsp;Cynthia S Crowson ,&nbsp;Ryan J Lennon ,&nbsp;John M Davis III ,&nbsp;Elena Myasoedova","doi":"10.1016/j.semarthrit.2024.152570","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To examine the role of cardiovascular disease (CVD) as a mediator in the pathway between rheumatoid arthritis (RA) and Alzheimer's disease and related dementias (ADRD).</div></div><div><h3>Methods</h3><div>This retrospective population-based study included patients over 50 years of age with incident RA, who met the 1987 ACR criteria in 1980–2014. This cohort was matched 1:1 on age, sex and index year to comparators without RA. Information on CVD events was manually extracted from electronic health records. The relationships between RA, CVD and ADRD were examined using Cox proportional hazard models. Time dependent mediation analysis was used to examine the role of CVD as a mediator between RA and ADRD.</div></div><div><h3>Results</h3><div>1754 individuals were included (877 persons with RA and 877 comparators without RA). During follow-up, 105 patients with RA and 102 individuals without RA developed ADRD; 444 patients with RA and 375 individuals without RA developed CVD. There was a non-significant association between RA and ADRD both without (aHR 1.27, 95 % CI 0.96, 1.69) and with (aHR 1.27, 95 % CI 0.95,1.68) CVD as a time dependent mediator. The mediation effect of any CVD on ADRD risk was not significant (<em>p</em> = 0.84). We found a significant interaction between RA and CVD on the risk of ADRD (aHR 1.95, 95 % CI 1.11, 3.42; <em>p</em> = 0.021).</div></div><div><h3>Conclusions</h3><div>The risk of ADRD in RA appears to be increased mainly in the presence of CVD. CVD was not a significant mediator on the risk of ADRD in RA. There was a significant synergistic effect of RA and CVD on ADRD risk.</div></div>","PeriodicalId":21715,"journal":{"name":"Seminars in arthritis and rheumatism","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in arthritis and rheumatism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0049017224002105","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To examine the role of cardiovascular disease (CVD) as a mediator in the pathway between rheumatoid arthritis (RA) and Alzheimer's disease and related dementias (ADRD).

Methods

This retrospective population-based study included patients over 50 years of age with incident RA, who met the 1987 ACR criteria in 1980–2014. This cohort was matched 1:1 on age, sex and index year to comparators without RA. Information on CVD events was manually extracted from electronic health records. The relationships between RA, CVD and ADRD were examined using Cox proportional hazard models. Time dependent mediation analysis was used to examine the role of CVD as a mediator between RA and ADRD.

Results

1754 individuals were included (877 persons with RA and 877 comparators without RA). During follow-up, 105 patients with RA and 102 individuals without RA developed ADRD; 444 patients with RA and 375 individuals without RA developed CVD. There was a non-significant association between RA and ADRD both without (aHR 1.27, 95 % CI 0.96, 1.69) and with (aHR 1.27, 95 % CI 0.95,1.68) CVD as a time dependent mediator. The mediation effect of any CVD on ADRD risk was not significant (p = 0.84). We found a significant interaction between RA and CVD on the risk of ADRD (aHR 1.95, 95 % CI 1.11, 3.42; p = 0.021).

Conclusions

The risk of ADRD in RA appears to be increased mainly in the presence of CVD. CVD was not a significant mediator on the risk of ADRD in RA. There was a significant synergistic effect of RA and CVD on ADRD risk.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心脑血管疾病对类风湿关节炎患者痴呆症风险的影响:中介分析
目的研究心血管疾病(CVD)在类风湿性关节炎(RA)与阿尔茨海默病及相关痴呆症(ADRD)之间的路径中作为介质的作用。在年龄、性别和指数年份方面,该队列与无RA的比较者进行了1:1匹配。心血管疾病事件的信息由人工从电子健康记录中提取。采用Cox比例危险模型研究了RA、心血管疾病和ADRD之间的关系。结果1754人被纳入研究(877名RA患者和877名未患RA的对比者)。在随访期间,105 名 RA 患者和 102 名非 RA 患者出现了 ADRD;444 名 RA 患者和 375 名非 RA 患者出现了心血管疾病。在没有(aHR 1.27,95 % CI 0.96,1.69)和有(aHR 1.27,95 % CI 0.95,1.68)心血管疾病作为时间依赖性中介的情况下,RA 与 ADRD 之间的关系均不显著。任何心血管疾病对 ADRD 风险的中介效应均不显著(p = 0.84)。我们发现 RA 和心血管疾病对 ADRD 风险有明显的交互作用(aHR 1.95,95 % CI 1.11,3.42;p = 0.021)。心血管疾病并不是RA患者ADRD风险的重要中介因素。RA和心血管疾病对ADRD风险有明显的协同作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.20
自引率
4.00%
发文量
176
审稿时长
46 days
期刊介绍: Seminars in Arthritis and Rheumatism provides access to the highest-quality clinical, therapeutic and translational research about arthritis, rheumatology and musculoskeletal disorders that affect the joints and connective tissue. Each bimonthly issue includes articles giving you the latest diagnostic criteria, consensus statements, systematic reviews and meta-analyses as well as clinical and translational research studies. Read this journal for the latest groundbreaking research and to gain insights from scientists and clinicians on the management and treatment of musculoskeletal and autoimmune rheumatologic diseases. The journal is of interest to rheumatologists, orthopedic surgeons, internal medicine physicians, immunologists and specialists in bone and mineral metabolism.
期刊最新文献
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus Primary headache in SLE –systematic review and meta-analysis Information and communication technology-based patient education for autoimmune inflammatory rheumatic diseases: A scoping review Improvement in spinal pain at night and its impact on long-term outcomes in radiographic axial spondyloarthritis: Results from Ixekizumab COAST-V randomised trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1